Reader Response: Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study.
作者信息
Feng Qian
机构信息
(Suzhou, China).
出版信息
Neurology. 2023 Oct 17;101(16):728-729. doi: 10.1212/WNL.0000000000207889.
Abstract
摘要
相似文献
1
Reader Response: Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study.
Neurology. 2023 Oct 17;101(16):728-729. doi: 10.1212/WNL.0000000000207889.
2
Author Response: Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study.
Neurology. 2023 Oct 17;101(16):729. doi: 10.1212/WNL.0000000000207890.
3
Efficacy and safety of novel oral anticoagulants in patients with atrial nonvalvular atrial fibrillation and diabetes mellitus: a systematic review and meta-analysis.
J Transl Med. 2022 Sep 30;20(1):441. doi: 10.1186/s12967-022-03652-9.
4
Comparative effectiveness and safety of rivaroxaban with other oral anticoagulants in older adults with nonvalvular atrial fibrillation: population-based analysis in response to updated Beers Criteria.
J Thromb Haemost. 2025 Feb;23(2):546-555. doi: 10.1016/j.jtha.2024.10.009. Epub 2024 Oct 21.
5
Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.
Clin Ther. 2013 Jul;35(7):967-984.e2. doi: 10.1016/j.clinthera.2013.05.011.
6
Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.
Am J Cardiol. 2012 Aug 1;110(3):453-60. doi: 10.1016/j.amjcard.2012.03.049. Epub 2012 Apr 24.
7
Dabigatran Versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice: A Systematic Review and Meta-Analysis.
Circ Cardiovasc Qual Outcomes. 2016 Mar;9(2):126-34. doi: 10.1161/CIRCOUTCOMES.115.002369. Epub 2016 Jan 26.
8
Relative efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation by network meta-analysis.
J Cardiovasc Med (Hagerstown). 2014 Dec;15(12):873-9. doi: 10.2459/JCM.0000000000000206.
9
Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
BMJ. 2017 Nov 28;359:j5058. doi: 10.1136/bmj.j5058.
10
Cost-effectiveness of new oral anticoagulants compared with warfarin in preventing stroke and other cardiovascular events in patients with atrial fibrillation.
Value Health. 2013 Jun;16(4):498-506. doi: 10.1016/j.jval.2013.01.009. Epub 2013 Apr 23.
本文引用的文献
1
Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study.
Neurology. 2023 Mar 21;100(12):e1309-e1320. doi: 10.1212/WNL.0000000000206748. Epub 2022 Dec 29.
Zotero 插件